Port implantation-related bloodstream infection caused by Wickerhamomyces myanmarensis: A case report

BACKGROUND AND PURPOSE: Wickerhamomyces myanmarensis is a new opportunistic yeast previously named Pichai myanmarensis, which belongs to the order Saccharomycetales. Since its discovery, one environmental isolate of W. myanmarensis has been reported from Myanmar, and one clinical sample from Iran. C...

Descripción completa

Detalles Bibliográficos
Autores principales: Aminasnafi, Ali, Khodavaisy, Sadegh, Moslem, Maryam, Esmaeilpour Jouneghani, Marziye, Sarbandi, Fatemeh, Falahatinejad, Mahsa, Bashardoust, Bahareh, Badali, Hamid, Kiasat, Neda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Iranian Society of Medical Mycology 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10590188/
https://www.ncbi.nlm.nih.gov/pubmed/37867594
http://dx.doi.org/10.18502/CMM.2023.150671
Descripción
Sumario:BACKGROUND AND PURPOSE: Wickerhamomyces myanmarensis is a new opportunistic yeast previously named Pichai myanmarensis, which belongs to the order Saccharomycetales. Since its discovery, one environmental isolate of W. myanmarensis has been reported from Myanmar, and one clinical sample from Iran. CASE REPORT: We report a case of bloodstream infection related to an implantable venous access port. W. myanmarensis was isolated from patient's blood after chemotherapy, which was meant to control and heal T-cell lymphoblastic lymphoma. Broth dilution minimum inhibitory concentrations were performed according to the CLSI M27-A3 document. The patient recovered with intravenous voriconazole and was discharged with the recommended prescription of oral voriconazole as a maintenance drug. CONCLUSION: So far, only one case of W. myanmarensis fungemia has been reported in the world in 2019. This is the second case of bloodstream infection with this yeast from a patient undergoing chemotherapy in Iran.

Ejemplares similares